Abstract
Summary
LPI (LP Information)' newest research report, the “Pre-Clinical Testing Service Industry Forecast” looks at past sales and reviews total world Pre-Clinical Testing Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Pre-Clinical Testing Service sales for 2023 through 2029. With Pre-Clinical Testing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Clinical Testing Service industry.
This Insight Report provides a comprehensive analysis of the global Pre-Clinical Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pre-Clinical Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pre-Clinical Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Clinical Testing Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Clinical Testing Service.
The global Pre-Clinical Testing Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pre-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pre-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pre-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pre-Clinical Testing Service players cover Pacific BioLabs(PBL), Charles River, Shanghai Medicilon, Eurofins Scientific, Pharmaceutical Outsourcing, NAMSA, Creative Biolabs, KMI Diagnostics and H-J Family of Companies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Clinical Testing Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
by Animal Model Species
Rabbit
Rat
Dog
Other
by Routes of Administration
Oral
Dermal
Intravenous
Subcutaneous
Intracutaneous
Intraperitoneal
Continuous Infusion
Intratracheal
Intrathecal
by Investigational Areas
Cardiovascular
Endocrine
Anti-infective
Oncology
Musculoskeletal
Dermal
Central Nervous System
Segmentation by application
Medicine
Health Products
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pacific BioLabs(PBL)
Charles River
Shanghai Medicilon
Eurofins Scientific
Pharmaceutical Outsourcing
NAMSA
Creative Biolabs
KMI Diagnostics
H-J Family of Companies
Phillips Medisize
Source Nutraceutical
Alanza
Elemental Analysis
This Insight Report provides a comprehensive analysis of the global Pre-Clinical Testing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pre-Clinical Testing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pre-Clinical Testing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Clinical Testing Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Clinical Testing Service.
The global Pre-Clinical Testing Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pre-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pre-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pre-Clinical Testing Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pre-Clinical Testing Service players cover Pacific BioLabs(PBL), Charles River, Shanghai Medicilon, Eurofins Scientific, Pharmaceutical Outsourcing, NAMSA, Creative Biolabs, KMI Diagnostics and H-J Family of Companies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Clinical Testing Service market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
by Animal Model Species
Rabbit
Rat
Dog
Other
by Routes of Administration
Oral
Dermal
Intravenous
Subcutaneous
Intracutaneous
Intraperitoneal
Continuous Infusion
Intratracheal
Intrathecal
by Investigational Areas
Cardiovascular
Endocrine
Anti-infective
Oncology
Musculoskeletal
Dermal
Central Nervous System
Segmentation by application
Medicine
Health Products
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pacific BioLabs(PBL)
Charles River
Shanghai Medicilon
Eurofins Scientific
Pharmaceutical Outsourcing
NAMSA
Creative Biolabs
KMI Diagnostics
H-J Family of Companies
Phillips Medisize
Source Nutraceutical
Alanza
Elemental Analysis
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pre-Clinical Testing Service Market Size 2018-2029
2.1.2 Pre-Clinical Testing Service Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pre-Clinical Testing Service Segment by Type
2.2.1 Rabbit
2.2.2 Rat
2.2.3 Dog
2.2.4 Other
2.3 Pre-Clinical Testing Service Market Size by Type
2.3.1 Pre-Clinical Testing Service Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pre-Clinical Testing Service Market Size Market Share by Type (2018-2023)
2.4 Pre-Clinical Testing Service Segment by Application
2.4.1 Medicine
2.4.2 Health Products
2.5 Pre-Clinical Testing Service Market Size by Application
2.5.1 Pre-Clinical Testing Service Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pre-Clinical Testing Service Market Size Market Share by Application (2018-2023)
3 Pre-Clinical Testing Service Market Size by Player
3.1 Pre-Clinical Testing Service Market Size Market Share by Players
3.1.1 Global Pre-Clinical Testing Service Revenue by Players (2018-2023)
3.1.2 Global Pre-Clinical Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Pre-Clinical Testing Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pre-Clinical Testing Service by Regions
4.1 Pre-Clinical Testing Service Market Size by Regions (2018-2023)
4.2 Americas Pre-Clinical Testing Service Market Size Growth (2018-2023)
4.3 APAC Pre-Clinical Testing Service Market Size Growth (2018-2023)
4.4 Europe Pre-Clinical Testing Service Market Size Growth (2018-2023)
4.5 Middle East & Africa Pre-Clinical Testing Service Market Size Growth (2018-2023)
5 Americas
5.1 Americas Pre-Clinical Testing Service Market Size by Country (2018-2023)
5.2 Americas Pre-Clinical Testing Service Market Size by Type (2018-2023)
5.3 Americas Pre-Clinical Testing Service Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pre-Clinical Testing Service Market Size by Region (2018-2023)
6.2 APAC Pre-Clinical Testing Service Market Size by Type (2018-2023)
6.3 APAC Pre-Clinical Testing Service Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pre-Clinical Testing Service by Country (2018-2023)
7.2 Europe Pre-Clinical Testing Service Market Size by Type (2018-2023)
7.3 Europe Pre-Clinical Testing Service Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pre-Clinical Testing Service by Region (2018-2023)
8.2 Middle East & Africa Pre-Clinical Testing Service Market Size by Type (2018-2023)
8.3 Middle East & Africa Pre-Clinical Testing Service Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pre-Clinical Testing Service Market Forecast
10.1 Global Pre-Clinical Testing Service Forecast by Regions (2024-2029)
10.1.1 Global Pre-Clinical Testing Service Forecast by Regions (2024-2029)
10.1.2 Americas Pre-Clinical Testing Service Forecast
10.1.3 APAC Pre-Clinical Testing Service Forecast
10.1.4 Europe Pre-Clinical Testing Service Forecast
10.1.5 Middle East & Africa Pre-Clinical Testing Service Forecast
10.2 Americas Pre-Clinical Testing Service Forecast by Country (2024-2029)
10.2.1 United States Pre-Clinical Testing Service Market Forecast
10.2.2 Canada Pre-Clinical Testing Service Market Forecast
10.2.3 Mexico Pre-Clinical Testing Service Market Forecast
10.2.4 Brazil Pre-Clinical Testing Service Market Forecast
10.3 APAC Pre-Clinical Testing Service Forecast by Region (2024-2029)
10.3.1 China Pre-Clinical Testing Service Market Forecast
10.3.2 Japan Pre-Clinical Testing Service Market Forecast
10.3.3 Korea Pre-Clinical Testing Service Market Forecast
10.3.4 Southeast Asia Pre-Clinical Testing Service Market Forecast
10.3.5 India Pre-Clinical Testing Service Market Forecast
10.3.6 Australia Pre-Clinical Testing Service Market Forecast
10.4 Europe Pre-Clinical Testing Service Forecast by Country (2024-2029)
10.4.1 Germany Pre-Clinical Testing Service Market Forecast
10.4.2 France Pre-Clinical Testing Service Market Forecast
10.4.3 UK Pre-Clinical Testing Service Market Forecast
10.4.4 Italy Pre-Clinical Testing Service Market Forecast
10.4.5 Russia Pre-Clinical Testing Service Market Forecast
10.5 Middle East & Africa Pre-Clinical Testing Service Forecast by Region (2024-2029)
10.5.1 Egypt Pre-Clinical Testing Service Market Forecast
10.5.2 South Africa Pre-Clinical Testing Service Market Forecast
10.5.3 Israel Pre-Clinical Testing Service Market Forecast
10.5.4 Turkey Pre-Clinical Testing Service Market Forecast
10.5.5 GCC Countries Pre-Clinical Testing Service Market Forecast
10.6 Global Pre-Clinical Testing Service Forecast by Type (2024-2029)
10.7 Global Pre-Clinical Testing Service Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Pacific BioLabs(PBL)
11.1.1 Pacific BioLabs(PBL) Company Information
11.1.2 Pacific BioLabs(PBL) Pre-Clinical Testing Service Product Offered
11.1.3 Pacific BioLabs(PBL) Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pacific BioLabs(PBL) Main Business Overview
11.1.5 Pacific BioLabs(PBL) Latest Developments
11.2 Charles River
11.2.1 Charles River Company Information
11.2.2 Charles River Pre-Clinical Testing Service Product Offered
11.2.3 Charles River Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Charles River Main Business Overview
11.2.5 Charles River Latest Developments
11.3 Shanghai Medicilon
11.3.1 Shanghai Medicilon Company Information
11.3.2 Shanghai Medicilon Pre-Clinical Testing Service Product Offered
11.3.3 Shanghai Medicilon Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Shanghai Medicilon Main Business Overview
11.3.5 Shanghai Medicilon Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Pre-Clinical Testing Service Product Offered
11.4.3 Eurofins Scientific Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Pharmaceutical Outsourcing
11.5.1 Pharmaceutical Outsourcing Company Information
11.5.2 Pharmaceutical Outsourcing Pre-Clinical Testing Service Product Offered
11.5.3 Pharmaceutical Outsourcing Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Pharmaceutical Outsourcing Main Business Overview
11.5.5 Pharmaceutical Outsourcing Latest Developments
11.6 NAMSA
11.6.1 NAMSA Company Information
11.6.2 NAMSA Pre-Clinical Testing Service Product Offered
11.6.3 NAMSA Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 NAMSA Main Business Overview
11.6.5 NAMSA Latest Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Information
11.7.2 Creative Biolabs Pre-Clinical Testing Service Product Offered
11.7.3 Creative Biolabs Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Creative Biolabs Main Business Overview
11.7.5 Creative Biolabs Latest Developments
11.8 KMI Diagnostics
11.8.1 KMI Diagnostics Company Information
11.8.2 KMI Diagnostics Pre-Clinical Testing Service Product Offered
11.8.3 KMI Diagnostics Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 KMI Diagnostics Main Business Overview
11.8.5 KMI Diagnostics Latest Developments
11.9 H-J Family of Companies
11.9.1 H-J Family of Companies Company Information
11.9.2 H-J Family of Companies Pre-Clinical Testing Service Product Offered
11.9.3 H-J Family of Companies Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 H-J Family of Companies Main Business Overview
11.9.5 H-J Family of Companies Latest Developments
11.10 Phillips Medisize
11.10.1 Phillips Medisize Company Information
11.10.2 Phillips Medisize Pre-Clinical Testing Service Product Offered
11.10.3 Phillips Medisize Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Phillips Medisize Main Business Overview
11.10.5 Phillips Medisize Latest Developments
11.11 Source Nutraceutical
11.11.1 Source Nutraceutical Company Information
11.11.2 Source Nutraceutical Pre-Clinical Testing Service Product Offered
11.11.3 Source Nutraceutical Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Source Nutraceutical Main Business Overview
11.11.5 Source Nutraceutical Latest Developments
11.12 Alanza
11.12.1 Alanza Company Information
11.12.2 Alanza Pre-Clinical Testing Service Product Offered
11.12.3 Alanza Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Alanza Main Business Overview
11.12.5 Alanza Latest Developments
11.13 Elemental Analysis
11.13.1 Elemental Analysis Company Information
11.13.2 Elemental Analysis Pre-Clinical Testing Service Product Offered
11.13.3 Elemental Analysis Pre-Clinical Testing Service Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Elemental Analysis Main Business Overview
11.13.5 Elemental Analysis Latest Developments
12 Research Findings and Conclusion